OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
September 27, 2006
The Part D donut hole has arrived, and pharma is scrambling to maintain brand loyalty.
A new, faster recipe for drug development: Chat up regulators. Outsource where you can. And know when to let go.
The recent settlement between branded and generic companies offers a 'win-win' approach to patent challenges.